The epilepsy treatment is now approved as an add-on therapy for patients aged ≥ 2 years, following an appeal against NICE’s initial rejection.

Children in England living with a rare and severe form of epilepsy could soon benefit from a new drug being rolled out on the ...

A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS ...

The National Institute for Health and Care Excellence (NICE) has approved fenfluramine (Fintepla) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in people aged 2 years and ...

New life-changing treatment option fenfluramine recommended for type of rare epilepsy, Lennox–Gastaut syndrome ...

The drug is the first non-cannabinoid option for patients with LGS and an alternative to Jazz Pharma's Epidyolex (cannabidiol ...

The girl had an incurable illness, but it was not deadly, Indiana doctors told police. The mother is now facing charges.

NICE has approved another epilepsy treatment for Lennox–Gastaut syndrome. Fenfluramine can be used as an add-on to other ...

People with a rare form of epilepsy in England will now have a new treatment option to try following approval by NICE.

Hope for children with severe form of epilepsy as NHS rolls out new drug - Fenfluramine has been recommended by Nice for ...

Fenfluramine has been recommended by the National Institute for Health and Care Excellence for patients aged two and over ...